Invivyd, Inc. (NASDAQ: IVVD) is a Healthcare company (Biotechnology) with a market capitalization of $151M. The Maz Rating grades it against the other companies in its sector.
Invivyd, Inc.'s current Maz Rating and its five factor grades are for members: log in to see them.
At $0.51, Invivyd, Inc. trades at 2.6x sales and 1.2x book value. Over the last twelve months it generated about $58M of revenue and a net loss of $122M. It runs a gross margin of 91.8%, an operating margin of -224.4% and a net margin of -214.8%. It shows return on equity of -67.2%, return on invested capital of -85.8% and a free cash flow yield of -84.6%. On the balance sheet: a debt-to-equity ratio of 0.05 and a current ratio of 5.51. Over the past 52 weeks the share price ranged from $0.49 to $3.01, with a beta of 0.71.
Invivyd, Inc. does not currently pay a dividend.
8 Wall Street analyst ratings cover the stock: 5 Buy and 3 Hold, for a Buy consensus. This is the sell side's view, separate from the Maz Rating.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.